Literature DB >> 8733378

Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection.

J Sánchez-Pérez1, M De Castro, G F Buezo, J Fernandez-Herrera, M J Borque, A García-Díez.   

Abstract

Although cases of lichen planus (LP) associated with hepatitis C virus (HCV) infection have been described, the association between the two diseases has not been established because the geographic origin of patients could be an important factor in HCV prevalence in patients with LP. The serum samples of 78 consecutive patients with cutaneous and/or mucous LP and 82 control patients were analysed for the presence of antibodies to HCV by enzyme-immunoassay and for the presence of antigens of HCV by two-stage polymerase chain reaction (PCR). The clinical features of patients with LP associated with HCV infection were compared with patients with LP without HCV infection. Sixteen of the 78 (20%) patients had anti-HCV antibodies. In 13 of these 16 cases (81%), HCV-RNA was detected by PCR in serum samples. In the 82 control patients, anti-HCV antibodies was observed in two (2.4%) patients. We have found a statistically significant association (P < 0.05) between erosive LP and HCV infection. We conclude that the high prevalence of HCV-RNA in patients with LP provides some evidence for the role of HCV in the pathogenesis of LP. Our results suggest an association between erosive LP and HCV infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8733378     DOI: 10.1111/j.1365-2133.1996.tb06977.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

Review 1.  Cutaneous manifestations of common liver diseases.

Authors:  Sunil Dogra; Rashmi Jindal
Journal:  J Clin Exp Hepatol       Date:  2012-01-02

2.  The prevalence of hepatitis C virus infection in patients with lichen planus in Gaziantep region of Turkey.

Authors:  N Kirtak; H S Inalöz; Z Erbağci
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

Review 3.  Association of oral lichen planus with chronic C hepatitis. Review of the data in literature.

Authors:  Carmen Gheorghe; Lelia Mihai; Ioanina Parlatescu; Serban Tovaru
Journal:  Maedica (Buchar)       Date:  2014-03

4.  The magnitude of the association between hepatitis C virus infection and oral lichen planus: meta-analysis and case control study.

Authors:  Stefano Petti; Maryam Rabiei; Massimo De Luca; Crispian Scully
Journal:  Odontology       Date:  2011-04-21       Impact factor: 2.634

5.  Low prevalence of necrolytic acral erythema in patients with chronic hepatitis C virus infection.

Authors:  Brian A Raphael; Zachariah L Dorey-Stein; Jason Lott; Valerianna Amorosa; Vincent Lo Re; Carrie Kovarik
Journal:  J Am Acad Dermatol       Date:  2012-02-09       Impact factor: 11.527

6.  Oral lichen planus - Review on etiopathogenesis.

Authors:  K Srinivas; K Aravinda; P Ratnakar; Nitin Nigam; Siddharth Gupta
Journal:  Natl J Maxillofac Surg       Date:  2011-01

7.  The prevalence of indices of hepatitis C and B infection, and elevated aminotransferase enzymes in patients with oral lichen planus (olp) in eastern saudi arabia.

Authors:  A M El-Rifaei; S E Fathalla; I H Al-Sheikh; M B Tinguria; Y A Qadry
Journal:  J Family Community Med       Date:  1998-07

8.  Lichen planus and Hepatitis C: a case-control study.

Authors:  S Zahra Ghodsi; Maryam Daneshpazhooh; Mohammad Shahi; Ali Nikfarjam
Journal:  BMC Dermatol       Date:  2004-05-20

9.  The prevalence of hepatitis C Virus (HCV) among lichen planus patients and its clinical pattern at the University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria.

Authors:  Agwu Bob Ukonu; Uhunmwangho Augustine
Journal:  Glob J Health Sci       Date:  2012-08-05

Review 10.  Hepatitis C Infection and Periodontal Disease: Is there a Common Immunological Link?

Authors:  Dorin Nicolae Gheorghe; Liliana Foia; Vasilica Toma; Amelia Surdu; Elena Herascu; Dora Maria Popescu; Petra Surlin; Cristin Constantin Vere; Ion Rogoveanu
Journal:  J Immunol Res       Date:  2018-03-13       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.